Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management
touchCASES for touchONCOLOGY
Join two international experts as they walk through three real-world patient stories, showing how molecular testing shapes treatment choices in advanced endometrial cancer and how immune-related side effects can be recognized and managed in everyday practice.
The experts:
Dr Nicoletta Colombo, European Institute of Oncology, Milan, Italy
Dr Ilaria Colombo, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
This activity is supported by an independent educational grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.